Human FHL1 knockout HeLa cell pellet (ab279093)
Properties
-
Storage instructions
Store at -80°C. Please refer to protocols. -
Components 1 kit Human FHL1 knockout HeLa cell pellet 1 vial Human wild-type HeLa cell pellet 1 vial -
Research areas
-
Cell type
epithelial -
Disease
Adenocarcinoma -
Gender
Female -
STR Analysis
Amelogenin X D5S818: 11, 12 D13S317: 12, 13.3 D7S820: 8, 12 D16S539: 9, 10 vWA: 16, 18 TH01: 7 TPOX: 8,12 CSF1PO: 9, 10
Images
-
Western blot - Human FHL1 knockout HeLa cell pellet (ab279093)
Lane 1:Wild-type HeLa cell lysate (20 ug)
Lane 2:FHL1 knockout HeLa cell lysate (20 ug)
Lane 3:HEK293T cell lysate (20 ug)
Lane 4:Daudi cell lysate (20 ug)ab255828 was shown to specifically react with FHL1 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab266011 (knockout cell lysate ab257952) was used. Wild-type and FHL1 knockout samples were subjected to SDS-PAGE. ab255828 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4oC at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
-
Sanger Sequencing - Human FHL1 knockout HeLa cell pellet (ab279093)Allele-1: 1 bp deletion in exon4
-
Sanger Sequencing - Human FHL1 knockout HeLa cell pellet (ab279093)Allele-2: Insertion of the selection cassette in exon4
